Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Maarten J. Titulaer, Lindsey McCracken, Iñigo Gabilondo et al. · The Lancet Neurology · 2013 · 3.1K citations

Life Sciences, Neurology, Neuroscience +13

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin, A.J. Grillo-López, Brian K. Link et al. · Journal of Clinical Oncology · 1998 · 2.8K citations

Pharmacy, Hematology, Immunology +17

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Josef S Smolen, André Beaulieu, Andrea Rubbert‐Roth et al. · The Lancet · 2008 · 1.4K citations

Medicine, Immunology, Pharmacology +16

The Management of Encephalitis: Clinical Practice Guidelines by the Infectious Diseases Society of America

Allan R. Tunkel, Carol Glaser, Karen C. Bloch et al. · Clinical Infectious Diseases · 2008 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Case Definitions, Diagnostic Algorithms, and Priorities in Encephalitis: Consensus Statement of the International Encephalitis Consortium

Arun Venkatesan, Allan R. Tunkel, Karen C. Bloch et al. · Clinical Infectious Diseases · 2013 · 1.2K citations · Full text

Public Health, Infectious Diseases, Neurology +17